Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Retaron® on Oxygen Induced Retinal Vasoconstriction in LPS Induced Inflammatory Model in Humans

NCT02221089 is registered in ClinicalTrials.gov with Medical University of Vienna as lead sponsor.

NCT NCT02221089
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02221089 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Retaron® on Oxygen Induced Retinal Vasoconstriction in LPS Induced Inflammatory Model in Humans
Lead sponsor
Medical University of Vienna
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2013
Completion date
July 31, 2014
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy subjects, imparied retinal vascular reactivity